The World Alzheimer Report 2021, to be published in September 2021, will focus on the crucial topic of diagnosis.
This webinar focuses on the global development and distribution of COVID-19 vaccines, including issues around equitable distribution and disinformation, as well as stories of success.
The February 2021 issue of our Global Perspective newsletter.
This webinar focuses on the clinical trial data for Biogen’s investigational drug aducanumab. If approved, aducanumab would be the first disease-modifying treatment for Alzheimer’s disease.
This webinar featured a panel discussion with experts from around the world who presented on the areas of dementia risk reduction, NCDs, air pollution, and the lived experience of dementia during COVID-19.
Our infographic showing 12 modifiable risk factors for dementia.
This webinar focuses on key issues emerging around dementia care and palliative care during the COVID-19 pandemic, and crucially how these can be taken forward.
The third Dementia Innovation Readiness Index focuses on city-level innovation readiness to dementia in 30 major cities globally.